Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
ValiRx plc ( (GB:VAL) ) has issued an announcement.
ValiRx plc announced the successful passing of all resolutions at its General Meeting, leading to the issuance of 241,999,999 new ordinary shares and an equal number of Fundraise Warrants. This fundraising effort is expected to enhance the company’s financial position, potentially improving its operations and market presence.
More about ValiRx plc
ValiRx is a life science company focused on early-stage cancer therapeutics and women’s health, aiming to accelerate the translation of innovative science into impactful medicines.
YTD Price Performance: -88.56%
Average Trading Volume: 1,918,959
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £893.4K
See more data about VAL stock on TipRanks’ Stock Analysis page.
Trending Articles
- Netflix (NASDAQ:NFLX) Lands Huge Win With “Squid Game 2”
- Ford (NYSE:F) Lands New Patent for “Steer-by-Wire” System
- Intel (NASDAQ:INTC) Looking Into Battlemage Followup
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
